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ABSTRACT Here, we report the complete genome sequences of 15 chikungunya vi-
rus strains isolated from human plasma from infected patients in Puerto Rico. The
results show that currently circulating chikungunya strains in Puerto Rico are closely
related.
Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes febrileillness associated with severe acute and persistent arthralgia (1). Recent CHIKV
outbreaks in the Indian Ocean and the introduction of the virus into the Americas in
2013 illustrate CHIKV’s reemergence as a global threat to public health (2). Currently,
there are no licensed vaccines or virus-specific therapies for treating acute or chronic
CHIKV disease (3). Thus, there is an urgent need for a better understanding of the
factors that contribute to CHIKV pathogenesis in order to develop safe and effective
vaccines and therapies.
CHIKV sequence diversity in currently circulating strains of CHIKV could impact the
efficacy of novel therapeutics targeting viral proteins. To determine the genetic diver-
sity of CHIKV in the current epidemic in the Americas, we sequenced multiple CHIKV
strains isolated from infected patients in Puerto Rico. Human serum samples from
patients positive for CHIKV by quantitative reverse transcriptase PCR were obtained by
the University of Puerto Rico. CHIKV infectious virus was amplified from serum samples
by a single passage on C6/36 mosquito cells. The virus was purified from cell super-
natants by centrifugation through a sucrose cushion. Genomic RNA was extracted from
sucrose-purified virions using TRIzol (Thermo Fisher Scientific). Virion RNA was reverse-
transcribed using random primers (Superscript II; Invitrogen) and converted to double-
stranded DNA using the NEBNext mRNA second-strand synthesis module (New England
Biolabs). Sequencing libraries were prepared using the Nextera XT DNA library prepa-
ration kit (Illumina) and sequenced using a MiSeq version 3 reagent kit (150 cycle)
(Illumina). Total reads were mapped to the CHIKV genome using Bowtie2 version 2.3.1
and a GenBank reference genome (accession no. EF452493.1). We obtained an average
coverage depth of 10 at each nucleotide. The consensus genome sequences were
derived from the most common nucleotide present at each coordinate.
Accession number(s). The complete genomic sequences for the 15 chikungunya virus
genomes reported here have been deposited in GenBank under the accession numbers
MF001505, MF001506, MF001507, MF001508, MF001509, MF001510, MF001511,
MF001512, MF001513, MF001514, MF001515, MF001516, MF001517, MF001518, and
MF001519.
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